This HTML5 document contains 36 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n7http://linked.opendata.cz/resource/drugbank/drug/DB07937/identifier/pdb/
n9http://linked.opendata.cz/resource/drugbank/drug/DB07937/identifier/pubchem-compound/
n10http://linked.opendata.cz/resource/drugbank/drug/DB07937/identifier/pubchem-substance/
n6http://linked.opendata.cz/resource/drugbank/drug/DB07937/identifier/drugbank/
n12http://bio2rdf.org/drugbank:
admshttp://www.w3.org/ns/adms#
n13http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n8http://linked.opendata.cz/resource/drugbank/drug/DB07937/identifier/chemspider/
owlhttp://www.w3.org/2002/07/owl#
n3http://linked.opendata.cz/ontology/drugbank/
n4http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#

Statements

Subject Item
n2:DB07937
rdf:type
n3:Drug
n3:group
experimental
owl:sameAs
n12:DB07937 n13:DB07937
dcterms:title
2-butoxy-9-(2,6-difluorobenzyl)-N-(2-morpholin-4-ylethyl)-9H-purin-6-amine
adms:identifier
n6:DB07937 n7:I24 n8:20575711 n9:16744441 n10:99444408
n3:IUPAC-Name
n4:271B4E05-363D-11E5-9242-09173F13E4C5
n3:InChI
n4:271B4E0B-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n4:271B4E0A-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n4:271B4E07-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n4:271B4E08-363D-11E5-9242-09173F13E4C5
n3:SMILES
n4:271B4E09-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n4:271B4E03-363D-11E5-9242-09173F13E4C5
n3:logP
n4:271B4E04-363D-11E5-9242-09173F13E4C5 n4:271B4E01-363D-11E5-9242-09173F13E4C5
n3:logS
n4:271B4E02-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n4:271B4E11-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n4:271B4E12-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n4:271B4E0C-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n4:271B4E0D-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n4:271B4E0F-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n4:271B4E0E-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n4:271B4E10-363D-11E5-9242-09173F13E4C5
n3:Bioavailability
n4:271B4E17-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n4:271B4E19-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n4:271B4E1A-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n4:271B4E16-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n4:271B4E15-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n4:271B4E18-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n4:271B4E06-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-acidic-
n4:271B4E13-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n4:271B4E14-363D-11E5-9242-09173F13E4C5